PATRICIA KENNERY: Open Payments
NPI 1295161016 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,921 in 166 payments from 21 companies in 2025. Trend: 2023 $2,453 · 2024 $1,921 · 2025 $3,921
Food & beverage: $3,822Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $682 |
| GlaxoSmithKline, LLC. | 35 | $635 |
| GENZYME CORPORATION | 15 | $333 |
| Merck Sharp & Dohme LLC | 10 | $315 |
| Regeneron Healthcare Solutions, Inc. | 12 | $283 |
| Inspire Medical Systems, Inc. | 7 | $235 |
| Verona Pharma, Inc. | 15 | $181 |
| Mallinckrodt Hospital Products Inc. | 6 | $165 |
| Actelion Pharmaceuticals US, Inc. | 3 | $161 |
| Grifols USA, LLC | 9 | $155 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, FASENRA, INSPIRE, WINREVAIR, TEZSPIRE, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
